Morphic Therapeutic

Morphic Therapeutic

Biotechnology company developing a new generation of oral integrin therapies.

HQ location
Waltham, United States
Launch date
Employees
Market cap
$2.9b
Enterprise value
$2.2b
Share price
$56.99 MORF
Authorizing premium user...